Total body irradiation before allogeneic and autologous bone marrow transplantation

A ten year Genoa experience

Daniele Scarpati, Renzo Corvó, Francesco Frassoni, Marina Guenzi, Angelo Carella, Gino Santini, Vito Vitale, Paola Franzone

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Since 1976 in Genoa, 291 TBI treatments were performed. Before allogeneic BMT, 1000 cGy/1 fx were prescribed in the first 22 patients, and then 990 cGy/3 fx/3 d in AML and CML, and the same or 1200 cGy/6 fx/3 d in ALL. Survival (S) and probability of remaining in remission (PRR) were 54% and 69% at 80 months in 80 AML; in 62 CML 45% and 60% at 60 months; in 69 ALL, 32% and 45% at 82 months. Differences in favour of higher doses and dose rates were observed and are presented. Before autologous BMT, 1000 cGy/1 fx were prescribed to AML and NHL, and 1200 cGy/3 fx/3 d to ALL patients. Disease free survival (DFS) was 71% and 13% at 82 months in 21 AML treated in first R and 9 ALL, respectively; 81 % at 32 months in 11 NHL treated in R.

Original languageEnglish
Pages (from-to)135-138
Number of pages4
JournalRadiotherapy and Oncology
Volume18
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 1990

Fingerprint

Autologous Transplantation
Whole-Body Irradiation
Bone Marrow Transplantation
Disease-Free Survival
Survival
Therapeutics

Keywords

  • Allogeneic BMT
  • Autologous BMT
  • TBI

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Urology

Cite this

Total body irradiation before allogeneic and autologous bone marrow transplantation : A ten year Genoa experience. / Scarpati, Daniele; Corvó, Renzo; Frassoni, Francesco; Guenzi, Marina; Carella, Angelo; Santini, Gino; Vitale, Vito; Franzone, Paola.

In: Radiotherapy and Oncology, Vol. 18, No. SUPPL. 1, 1990, p. 135-138.

Research output: Contribution to journalArticle

@article{7d6fc6ef7fa8485781cdbfe05313c349,
title = "Total body irradiation before allogeneic and autologous bone marrow transplantation: A ten year Genoa experience",
abstract = "Since 1976 in Genoa, 291 TBI treatments were performed. Before allogeneic BMT, 1000 cGy/1 fx were prescribed in the first 22 patients, and then 990 cGy/3 fx/3 d in AML and CML, and the same or 1200 cGy/6 fx/3 d in ALL. Survival (S) and probability of remaining in remission (PRR) were 54{\%} and 69{\%} at 80 months in 80 AML; in 62 CML 45{\%} and 60{\%} at 60 months; in 69 ALL, 32{\%} and 45{\%} at 82 months. Differences in favour of higher doses and dose rates were observed and are presented. Before autologous BMT, 1000 cGy/1 fx were prescribed to AML and NHL, and 1200 cGy/3 fx/3 d to ALL patients. Disease free survival (DFS) was 71{\%} and 13{\%} at 82 months in 21 AML treated in first R and 9 ALL, respectively; 81 {\%} at 32 months in 11 NHL treated in R.",
keywords = "Allogeneic BMT, Autologous BMT, TBI",
author = "Daniele Scarpati and Renzo Corv{\'o} and Francesco Frassoni and Marina Guenzi and Angelo Carella and Gino Santini and Vito Vitale and Paola Franzone",
year = "1990",
doi = "10.1016/0167-8140(90)90194-2",
language = "English",
volume = "18",
pages = "135--138",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Total body irradiation before allogeneic and autologous bone marrow transplantation

T2 - A ten year Genoa experience

AU - Scarpati, Daniele

AU - Corvó, Renzo

AU - Frassoni, Francesco

AU - Guenzi, Marina

AU - Carella, Angelo

AU - Santini, Gino

AU - Vitale, Vito

AU - Franzone, Paola

PY - 1990

Y1 - 1990

N2 - Since 1976 in Genoa, 291 TBI treatments were performed. Before allogeneic BMT, 1000 cGy/1 fx were prescribed in the first 22 patients, and then 990 cGy/3 fx/3 d in AML and CML, and the same or 1200 cGy/6 fx/3 d in ALL. Survival (S) and probability of remaining in remission (PRR) were 54% and 69% at 80 months in 80 AML; in 62 CML 45% and 60% at 60 months; in 69 ALL, 32% and 45% at 82 months. Differences in favour of higher doses and dose rates were observed and are presented. Before autologous BMT, 1000 cGy/1 fx were prescribed to AML and NHL, and 1200 cGy/3 fx/3 d to ALL patients. Disease free survival (DFS) was 71% and 13% at 82 months in 21 AML treated in first R and 9 ALL, respectively; 81 % at 32 months in 11 NHL treated in R.

AB - Since 1976 in Genoa, 291 TBI treatments were performed. Before allogeneic BMT, 1000 cGy/1 fx were prescribed in the first 22 patients, and then 990 cGy/3 fx/3 d in AML and CML, and the same or 1200 cGy/6 fx/3 d in ALL. Survival (S) and probability of remaining in remission (PRR) were 54% and 69% at 80 months in 80 AML; in 62 CML 45% and 60% at 60 months; in 69 ALL, 32% and 45% at 82 months. Differences in favour of higher doses and dose rates were observed and are presented. Before autologous BMT, 1000 cGy/1 fx were prescribed to AML and NHL, and 1200 cGy/3 fx/3 d to ALL patients. Disease free survival (DFS) was 71% and 13% at 82 months in 21 AML treated in first R and 9 ALL, respectively; 81 % at 32 months in 11 NHL treated in R.

KW - Allogeneic BMT

KW - Autologous BMT

KW - TBI

UR - http://www.scopus.com/inward/record.url?scp=0025622788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025622788&partnerID=8YFLogxK

U2 - 10.1016/0167-8140(90)90194-2

DO - 10.1016/0167-8140(90)90194-2

M3 - Article

VL - 18

SP - 135

EP - 138

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

IS - SUPPL. 1

ER -